Primitive quiescent CD34+ cells in chronic myeloid leukemia are targeted by in vitro expanded natural killer cells, which are functionally enhanced by bortezomib.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples